No preview available

Download the file

Analytics

Gefitinib and carboplatin combinations in breast cancer-derived cell lines. Cells were treated for 72 h with constant ratios of the IC50 doses for both gefitinib and carboplatin. Combination Index (CI) values below one are synergistic, equal to one Public

File Details

Depositor
rkati
Date Uploaded
Date Modified
2019-05-06
Fixity Check
Fixity checks have not yet been run on this object
Characterization
File Format: vnd.adobe.illustrator (Portable Document Format, Adobe Illustrator)
Page Count: 1
File Size: 189068
Original Checksum: 32275a8dbbc380b71966c7c32f3fdf0d
Mime Type: application/vnd.adobe.illustrator
User Activity Date
User rkati@ad.unc.edu has attached Gefitinib and carboplatin combinations in breast cancer-derived cell lines. Cells were treated for 72 h with constant ratios of the IC50 doses for both gefitinib and carboplatin. Combination Index (CI) values below one are synergistic, equal to one to EGFR associated expression profiles vary with breast tumor subtype May 6th, 2019 15:48